Comparison of plasma microRNAs with CTCs and PSA in patients treated on SWOG S0925, a randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone for patients with new metastatic hormone-sensitive prostate cancer.
Heather H. Cheng
No relevant relationships to disclose
Hongli Li
No relevant relationships to disclose
Celestia S. Higano
Research Funding - ImClone Systems
Catherine M. Tangen
No relevant relationships to disclose
Neeraj Agarwal
Consultant or Advisory Role - Exelixis (U); Medivation (U)
Honoraria - Dendreon
Research Funding - Amgen; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; ImClone Systems; Medivation; Novartis; Pfizer; Takeda
James Yan
No relevant relationships to disclose
Nicholas J. Vogelzang
Consultant or Advisory Role - Veridex
Honoraria - Veridex
Maha Hussain
Research Funding - ImClone Systems
Ian Murchie Thompson
No relevant relationships to disclose
Muneesh Tewari
No relevant relationships to disclose
Evan Y. Yu
Research Funding - ImClone Systems; Veridex